National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Agency: National Institutes of Health
NAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Posted: 2023-12-15
Deadline: 2027-01-07
Estimated funding: 0
Award ceiling: 0